Haemochromatosis UK takes a look at the world of Clinical Trials

As a charity and patient organisation, Haemochromatosis UK (HUK) is interested in new research about haemochromatosis. As this is increasingly a priority for HUK as well as our members, HUK wants to make sure that we are always up to date on all of the key information about haemochromatosis and respond to new medical research.

Clinical trials for new treatments are a key part of the medical research process. In this article, we give some information about clinical trials. You may find the below article interesting and helpful if you want to know more about new medical treatments or if you are thinking about participating in a drug trial.

>> Information about Clinical Trials


Notes

Haemochromatosis/GH is a genetic disorder causing the body to absorb excessive iron from the diet. Characterised by joint pain and disease, chronic fatigue and weakness, cognitive and psychological difficulties, sexual health issues, skin problems, abnormal liver function, diabetes, and cardiomyopathy. Iron overload can be fatal. It is usually easily treated if diagnosed early.

If you believe you have haemochromatosis or any other condition, please talk to your GP.